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Abstract
Asymmetric catalysis represents a very powerful tool for the synthesis of enantiopure compounds. In this context the main focus
has been directed not only to the search for new efficient chiral catalysts, but also to the development of efficient pronucleophiles.
This review highlights the utility and first examples of 1H-imidazol-4(5H)-ones and thiazol-4(5H)-ones as pronucleophiles in cata-
lytic asymmetric reactions.
Introduction
Asymmetric catalysis [1-3] constitutes a very powerful tool for
the preparation of enantiomerically pure compounds [4]. Recent
efforts in the field have been devoted to the development of
new efficient chiral catalysts, both metal catalysts and organo-
catalysts, together with the search for appropriate (pro)nucleo-
philes and/or electrophiles. In this context, the enantioselective
construction of tetrasubstituted stereocenters is another chal-
lenge [5-13]. Regarding reactions which involve proton transfer
events, soft enolization [14-16] constitutes an efficient tool for
the deprotonation of some carbonyl compounds [17,18]. In
these cases, a relatively weak amine is generally used to revers-
ibly deprotonate a relatively acidic substrate; however, to date,
the carbonyl components for these reactions are mostly
restricted to 1,3-diones, β-ketoesters, malonates, α-cyano-
acetates, 3-substitued oxindoles and related systems. Generally,
enolizable esters or carboxylic acid derivatives have been chal-
lenging in this strategy, because their pKa values (approxi-
mately 19 in DMSO) [19] are much higher, one exception being
thioesters [20,21] and pyrazoleamides [22]. As an alternative,
some specific heterocycles have been proposed as carboxylic
acid surrogates. Examples of this type of heterocycles are
oxazol-5-(4H)-ones (or azlactones) and their analogues
(Figure 1a) and oxazol-4-(5H)-ones and their thiazolone and
imidazolone analogues (Figure 1b).
These heterocycles show very interesting characteristics: i) easy
deprotonation under soft enolization conditions (aromatic
enolate formation); ii) the geometry of the resulting starting
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Figure 1: Some α-substituted heterocycles for asymmetric catalysis, their reactivity patterns against enolization, and resulting adducts after catalytic
reaction and hydrolysis.
enolate or equivalent is fixed due to their cyclic nature, thus
facilitating the control of the stereoselectivity; iii) they are
substituted at the α-position of the carbonyl and therefore, after
reaction with an electrophile, a tetrasubstituted stereocenter is
created and, iv) the resulting adducts can be easily hydrolyzed
to provide carboxylic acids or their derivatives carrying differ-
ent functionalities.
The most common pronucleophiles of this type are oxazol-5-
(4H)-ones or azlactones (Figure 1a, X = O), which have been
thoroughly investigated and reviewed [23-25]. On the other
hand, since the pionnering work by Trost in 2004 [26], several
examples of the utility of the structurally related oxazol-4(5H)-
ones (Figure 1b, X = O) have also been published, which
involve mainly Michael additions (to enones [27,28], nitro-
alkenes [29,30], alkynones [31-33] and vinyl sulfones [34]),
γ-additions to allenic ketones and esters [35,36], 1,6-additions
to conjugated dienones [37], aldol/Mannich reactions [26,38-
40], α-sulfenylation reactions [41] and alkylations [42,43].
More recently the nitrogen (1H-imidazol-4(5H)-ones,
Figure 1b, X = NR’) and sulfur (thiazol-4(5H)-ones, Figure 1b,
X = S) analogues of these oxazol-4(5H)-ones have been demon-
strated to be very interesting templates in asymmetric catalysis.
In these cases the hydrolysis of the adducts coming from an
asymmetric reaction can provide enantioenriched α-hydroxy
acids (X = O), N-substituted α-amino acids (X = NR’) or
α-mercapto acids (X = S) depending on the nature of the
starting heterocycle. This review describes the first examples
and applications of 1H-imidazol-4(5H)-ones 1 and thiazol-
4(5H)-ones 2 (Figure 2) as emerging pronucleophiles in asym-
metric catalytic reactions.
Figure 2: 1H-Imidazol-4(5H)-ones 1 and thiazol-4(5H)-ones 2.
Review
1 1H-Imidazol-4(5H)-ones 1
α,α-Disubstituted (quaternary) amino acids are compounds and/
or scaffolds of demanding continuous interest [44] and many
stereoselective protocols have been developed for their synthe-
ses [44-50]. In this field, particularly interesting are N-substi-
tuted derivatives, which are potentially good therapeutical
candidates because of their high lipophilicity and membrane
permeability [44,51]. A major catalytic entry to α,α-disubsti-
tuted (quaternary) amino acids is the α-functionalization of an
appropriate template as, for instance, an α-imino ester or
lactone, followed by hydrolysis [49,52,53]; but, however, very
few of them provide N-substituted derivatives directly [54]. In
this context, 1H-imidazol-4(5H)-ones 1 have been recently
introduced as novel nucleophilic α-amino acid equivalents for
the catalytic and asymmetric synthesis of N-alkyl, N-aryl and
N-allyl α,α-disubstituted amino acids [55]. The main advan-
tages of these pronucleophiles over the previous known tem-
plates are: i) the NR group can be installed in the heterocycle
previous to the asymmetric reaction, ii) they are easily deproto-
nated under soft enolization conditions (aromatic enolate forma-
Beilstein J. Org. Chem. 2016, 12, 918–936.
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tion), and iii) unlike azlactones and analogous they do not show
the Cα/Cγ selectivity problem [56-58].
1.1 Synthesis of 1H-imidazol-4(5H)-ones 1
1H-Imidazol-4(5H)-ones 1 (R = SBn) are prepared by S-alkyl-
ation of the corresponding thiohydantoins [55,59] (Scheme 1a)
prior trimethylsilyl enol ether formation which is necessary to
avoid O-alkylation. The starting thiohydantoins, in turn, are ob-
tained by heating a mixture of the corresponding N-substituted
amino acid or its methyl ester 3 and thiourea at 195 °C [59]
(Scheme 1b). Following this protocol different 1H-Imidazol-
4(5H)-ones have been prepared in good yields.
Scheme 1: a) Synthesis of 2-thio-1H-imidazol-4(5H)-ones [55] and
b) preparation of the starting thiohydantoins [59].
1.2 1H-Imidazol-4(5H)-ones 1 as pronucleophiles in
organocatalyzed Michael addition reactions
2-Thio-1H-imidazol-4(5H)-ones 1 (R = SBn) have been re-
ported to be effective equivalents of N-subtituted (alkyl, aryl,
allyl) α-amino acids in conjugate addition reactions to both,
nitroalkenes and α-silyloxy enones as Michael acceptors in
reactions promoted by bifunctional Brønsted bases.
1.2.1 Nitroalkenes as acceptors. Investigation of the base-cata-
lyzed Michael addition reaction of 2-thio-1H-imidazol-4(5H)-
ones 4 to nitroalkenes 5 [55] revealed that cinchona alkaloids
such as quinine, (DHQ)2Pyr or even thiourea tertiary amine
catalysts were not efficient in terms of stereoselectivity. How-
ever, good results regarding both, yield and stereocontrol, were
observed when the Rawal catalyst C1 [60,61] was employed
(Scheme 2).
Under the optimized conditions the reaction, as shown in
Scheme 2, worked equally well regardless of the electronic
character of the β-aryl substituent of nitroalkene 5 (compounds
6–8). Different substituents either at the nitrogen atom of the
starting imidazolone (compounds 9–11) or at the 5-position
(compound 12) of the ring are also well tolerated. Reactions
with β-alkyl nitroolefins in the presence of C1 (Scheme 2, com-
pounds 13–15) proceeded with poor diastereocontrol but the
results were improved by changing to catalyst C2 [62].
Nonetheless, in both cases the enantioselectivity for the major
diastereomer was excellent. Finally, and starting from the corre-
sponding bicyclic imidazolones, quaternary proline and related
derivatives (16–18), which are difficult to obtain through estab-
lished catalytic methodologies [63-65], can also be efficiently
synthesized.
On the other hand, it is worthy of note that thiohydantoins,
which are structurally related to 2-thio-1H-imidazol-4(5H)-ones
1, have been demonstrated to be either less reactive and/or less
stereoselective in their addition reaction to nitrostyrene thus
affording the corresponding Michael adducts with no diastereo-
selectivity and/or poor enantioselectivity (Scheme 3).
Useful applications of the Michael adducts coming from the
Michael addition of imidazolones to nitroalkenes are shown by
the transformations depicted in Scheme 4. Thus, nucleophilic
displacement of the thioether group gives access to various
types of heterocycles of interest in medicinal chemistry [66,67]
(i.e., imidazolidinones 19 and 20, 2-arylimidazolone 22,
2-aminoimidazolone 23 and hydantoins 24–26). On the other
hand, acid hydrolysis of these adducts efficiently affords
N-alkylamino acid derivatives, as for instance the N-methyl-
amino amide 21. Additionally, from the common adduct 26,
functionalized polycyclic hydantoins of type 27 and 28 can also
be synthesized.
The authors proposed an heuristic model (Figure 3) to account
for the experimentally encountered selectivity where the cata-
lyst is proposed to act in a bifunctional way. In this proposal the
imidazolone would be coordinated to the two NH bonds of the
squaramide and the ortho-ArH in C1, whilst the nitroalkene
would form a hydrogen bond by coordination to the protonated
Beilstein J. Org. Chem. 2016, 12, 918–936.
921
Scheme 2: Selected examples of the Michael addition of 2-thio-1H-imidazol-4(5H)-ones to nitroalkenes [55]. aReactions run at 50 °C in CH2Cl2.
bUsing catalyst C2.
tertiary amine through the oxygen of the nitro group. This
assumption was supported by the fact that the chemical shift of
the ortho-ArH in C1 varies considerably after the addition of
1 equivalent of imidazolone to a solution of C1 in CDCl3,
whereas it doesn’t change after the addition of nitrostyrene.
1.2.2 α-Silyloxyenones as acceptors. Among Michael accep-
tors, simple α,β-unsaturated esters and amides still are chal-
lenging substrates in direct Michael additions and have only
been employed in few successful Michael reactions, mainly due
to their inherent lower reactivity and the limitations associated
to the activation/coordination of these compounds to a suitable
chiral catalyst. Although recently it has been shown that the
problem of this low reactivity may be addressed through the de-
velopment of Brønsted base catalysts with increased basicity
[68], most efforts still focus on the development of unsaturated
ester/amide surrogates [69-71], which involve α,β-unsaturated
imides, N-acyl heterocycles, α-oxophosphonates, α-ketoesters,
3-methyl-4-nitro-5-alkenylisoxazoles and α’-hydroxyenones.
These latter substrates have proven to be very efficient plat-
forms for bidentate coordination in metal catalysis and good
precursors of carboxylic acids, ketones and aldehydes upon oxi-
dative cleavage of the keto/diol moiety [72]. More recently, a
comprehensive study on the first evidence of the utility of these
acceptors in organocatalysis has been published [73]. This study
shows that α’-oxyenones are very efficient key enoate equiva-
Beilstein J. Org. Chem. 2016, 12, 918–936.
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Scheme 3: Michael addition of thiohydantoins to nitrostyrene assisted by Et3N and catalysts C1 and C3. aAbsolute configuration not determined.
Scheme 4: Elaboration of the Michael adducts coming from the Michael addition to nitroalkenes [55].
Beilstein J. Org. Chem. 2016, 12, 918–936.
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Figure 3: Proposed model for the Michael addition of 1H-imidazol4-
(5H)-ones and selected 1H NMR data which support it [55].
lents in Brønsted base-catalyzed asymmetric conjugate addition
of a range of soft nucleophiles such as α-substituted oxindoles,
cyanoesters, oxazolones, azlactones and thiazolones to afford
the corresponding tetrasubstituted Michael adducts in high
diastereo- and enantioselectivity. The efficiency of the previous
2-thio-imidazol-4(5H)-ones as pronucleophiles in Michael reac-
tions has also been corroborated in the addition to these α-silyl-
oxyenones as Michael acceptors [55].
First attempts to carry out the Michael addition reaction of
imidazolones to simple unsaturated esters and ketones revealed
that whilst these reactions worked sluggish, they proceeded effi-
ciently when α-silyloxyenones were used as Michael acceptors.
In these cases and, under the conditions shown in Scheme 5,
reaction of the 1,5-dimethylimidazolone 4 (R1 = R2 = Me) in
the presence of catalyst C1 afforded, after desilylation, the
Michael adduct 30 in good yield (74%) but in moderate enantio-
selectivity (−84%). Improved selectivity (91%) was observed
using C2 in the reaction with 4 (R 1= R2 = Me) and even better
enantioselectivity was obtained with catalysts C3 (94%) and C4
(96%). Under these optimized conditions a survey of imida-
zolones reacted with enone 29 to produce adducts with yields
within the range 71–83% and with very high enantioselectivity
(Scheme 5).
The Michael adducts can also be transformed into different de-
rivatives (Scheme 6), particularly into hydantoins 37–43 after
hydrolysis of the corresponding adducts 30–32 [55]. Oxidative
elaboration of the ketol unit in these compounds provides the
corresponding carboxylic acids 40/41, the aldehyde 42 and the
ketone 43. Therefore this methodology facilitates a novel entry
to functionalized 5,5-disubstituted hydantoins, a well-recog-
nized scaffold for drug discovery.
2 Thiazol-4(5H)-ones 2
Thiazol-4(5H)-ones 2, which exhibit interesting applications in
medicinal and pharmaceutical areas [74-76], can be easily syn-
thesized and can act as (pro)nucleophiles in asymmetric catalyt-
ic reactions. In 2011, Weib and Beckert et al. reported a
1H NMR study of these compounds in solution that shows that
they exist in equilibrium between two tautomeric forms [77],
and therefore this could facilitate deprotonation at the 5-posi-
tion to further react with various electrophiles. However,
thiazol-4(5H)-ones have been until now rarely used in asym-
metric catalysis, and only very recently four interesting exam-
ples describing their applications in this realm have been re-
ported. On the other hand, rhodanines 44 and 45 (Scheme 7),
heterocycles structurally related to thiazol-4(5H)-ones 2, have
also been very scarcely used as pronucleophiles in asymmetric
catalysis. Only few examples have been reported, some of them
involving the use of rhodanines of type 44 (Scheme 7a), which
act directly as pronucleophiles against enones [78]
(Scheme 7a,1), enals [79] (a,2) and azodicarboxylates [80]
(a,3). In two other examples (Scheme 7b), however, rhodanines
of type 45 have been employed to produce spirocyclic com-
pounds. The first case is an enamine/Michael tandem reaction to
unsaturated enones [81] (Scheme 7b,1) and the second one is
the Diels–Alder reaction with 2,4-dienals which occurs via
trienamine formation [82] (Scheme 7b,2).
2.1 Synthesis of thiazol-4(5H)-ones 2
Thiazol-4(5H)-ones 2 can be easily prepared starting from the
corresponding α-mercaptocarboxylic acid and nitrile. Treat-
ment of both with triethylamine in refluxing ethanol [83]
provides the expected thiazol-4(5H)-ones as yellow/green solids
in good yields. The starting α-mercaptocarboxylic acids can be
prepared by reaction of the corresponding α-bromo derivatives
with potassium thioacetate followed by treatment with ammonia
in methanol [84].
2.2 Thiazol-4(5H)-ones 2 as pronucleophiles in
asymmetric catalytic reactions
The potential of thiazol-4(5H)-ones as pronucleophiles in asym-
metric catalytic reactions has been investigated in the Michael
addition reaction to nitroalkenes and α-silyloxyenones, phos-
phine-catalyzed γ-addition to allenoates and alkynoates,
α-amination reactions and iridium-catalyzed allylic substitution
reactions.
2.2.1 Michael addition reactions, nitroalkenes as acceptors.
The first example of the utility of the thiazol-4(5H)-ones 2 as
pronucleophiles in asymmetric catalysis was reported in 2013
in the Michael addition to nitroalkenes catalyzed by the
bifunctional ureidopeptide-like Brønsted base C5 (Scheme 8)
[85].
Beilstein J. Org. Chem. 2016, 12, 918–936.
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Scheme 5: Michael addition 2-thio-1H-imidazol-4(5H)-ones to the α-silyloxyenone 29 [55].
Scheme 6: Elaboration of the Michael adducts coming from the Michael addition to nitroolefins [55].
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Scheme 7: Rhodanines in asymmetric catalytic reactions: a) Reaction with rhodanines of type 44 [78-80]; b) reactions with rhodanines of type 45
[81,82].
This catalyst belongs to a new subclass of bifunctional Brønsted
bases, which was developed on the basis of Takemoto’s model
[86]. This model is featured by three different moieties: a basic
site, a urea (thiourea) function and a 3,5-bis(trifluoromethyl)-
phenyl group, all three elements being necessary for catalyst ac-
tivity (Figure 4a) [87-89]. In 2010 Zhong proposed that the
presence of the ortho C–H bond of the aryl group could be the
key for success because it could participate together with the
thiourea function in the activation of the electrophile [90]. This
proposal was in 2012 supported by Schreiner [91] after an
exhaustive study based on NMR/IR spectroscopy, mass spec-
trometry and theoretical DFT calculations. By taking into
account these characteristics, the authors considered that the
combination of ureidopetide’s structure, which have been
recognized by their ability to develop hydrogen bond interac-
tions [92-95] with a Brønsted base could provide a new family
of potentially efficient bifunctional catalysts (Figure 4b). The
main features of these new catalysts are the presence of a urea
moiety together with a N,N-diacylaminal unit, both in close
proximity to an additional stereodirecting group.
Beilstein J. Org. Chem. 2016, 12, 918–936.
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Scheme 8: Michael addition of thiazol-4(5H)-ones to nitroolefins promoted by the ureidopeptide-like bifunctional Brønsted base catalyst C5 [85].
Figure 4: Ureidopeptide-like Brønsted bases: catalyst design. a) Previous known design. b) Proposed new design. BB: Brønsted base [85].
Following this design and starting from the corresponding
N-protected α-amino acid 46 different catalysts were easily syn-
thesized by the reaction of the respective intermediate isocya-
nates 47 [93] with 9-epi-9-amino-9-deoxyquinine or 9-epi-9-
amino-9-deoxyhydroquinine (Scheme 9). These catalysts were
tested in the reaction between 5-methylthiazolone 49 and nitro-
styrene (Scheme 10) and after optimization catalyst C5 was
found to be the optimal for this transformation.
A representative selection of nitroalkenes was then evaluated in
the presence of catalyst C5 and, as the data in Scheme 10 show,
those bearing β-aryl substituents with either electron-donating
or electron-withdrawing groups produced the corresponding
adducts in good enantio- and diastereoselectivities (compounds
53–59). Even the most problematic β-alkyl nitroalkenes worked
well affording the adducts in good stereoselectivity albeit in
poor yields (Scheme 10, compounds 60–62). The reaction was
equally efficient with thiazolones carrying short and large alkyl
chains (Scheme 10, compounds 63–66).
An aspect of practical interest of this methodology is that whilst
the majority of the procedures for the preparation of organo-
sulfur compounds render thioether derivatives [96,97], this ap-
proach provides products with a free thiol group such as the
Beilstein J. Org. Chem. 2016, 12, 918–936.
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Scheme 10: Selected examples of the Michael addition of thiazolones to different nitroolefins promoted by catalyst C5 [85].
Scheme 9: Ureidopeptide-like Brønsted base bifunctional catalyst
preparation. NMM = N-methylmorpholine, THF = tetrahydrofuran [85].
α-mercaptocarboxylic acid derivative 67 (Scheme 11). Addi-
tionally, these mercapto derivatives can also be S-alkylated by
treatment with the corresponding halide in the presence of sodi-
um hydride, giving thus access to thioether derivatives of type
68, which can also be converted into γ-lactams such as 69.
On the other hand, experiments carried out with pyridyl and
quinoylthiazolone substrates reveal that in these cases selec-
tivity is higher than with the phenyl and 2-naphthylthiazolones,
respectively (Scheme 12, compound 70 versus 71 and 72 versus
73). On this basis, the authors propose a bifunctional way of
action of the catalyst, wherein the pyridine/quinoline nitrogen
could coordinate to one of the free N–H hydrogen atoms of the
catalyst.
α’-Silyloxyenones as acceptors. As in the case of imida-
zolones, thiazolones also exhibit very poor reactivity in the
Beilstein J. Org. Chem. 2016, 12, 918–936.
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Scheme 11: Elaboration of the Michael adducts to α,α-disubstituted α-mercaptocarboxylic acid derivatives [85].
Scheme 12: Effect of the nitrogen atom at the aromatic substituent of the thiazolone on yield and stereoselectivity in the Michael addition to nitro-
styrene [85].
Michael addition to methyl and tert-butyl acrylates. This prob-
lem could be circumvented by using α’-silyloxyenones as acry-
late surrogates [73]. After catalyst screening and optimization
of the reaction conditions the authors found that thiazolones 74
bearing either short, large or ramified alkyl chains at the hetero-
cycle afforded the corresponding Michael adducts in good
yields and excellent enantioselectivity in the presence of
20 mol % of catalyst C3 (Scheme 13). Initial attempts to carry
out the reactions with the α’-hydroxyenone provided the
adducts in very poor enantioselectivity. This is a particular and
interesting characteristic of these templates because the
α-hydroxy group can be transformed into other oxy derivatives
to better adapt to the most suitable substrate/catalyst interaction.
In addition, adducts 76 and 77 were easily transformed into the
corresponding carboxylic acids 79 and 80 by treatment with
periodic acid (Scheme 14) and thiolactone 81 by simple ring
opening of the latter under mild acidic conditions.
Beilstein J. Org. Chem. 2016, 12, 918–936.
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Scheme 13: Michael addition reaction of thiazol-4(5H)ones 74 to α’-silyloxyenone 29 [73].
Scheme 14: Elaboration of the thiazolone Michael adducts [73].
Phosphine-catalyzed γ-addition to allenoates and alkyno-
ates. Chiral phosphine-mediated nucleophilic catalysis has at-
tracted considerable attention in the recent years [98-101].
However, few examples of phosphine-mediated γ-addition reac-
tions have been reported. Pioneering studies on γ-additions of
pronucleophiles to allenoates or alkynoates were first published
by the groups of Trost [102-104] and Lu [105] in the 1990s.
However, asymmetric variants were not reported until more
than a decade later. The group of Fu has recently described the
enantioselective γ-addition of oxygen [106,107], carbon [108],
sulfur [109], and nitrogen [110] pronucleophiles to γ-substi-
tuted allenoates and/or alkynoates in the presence of a C2-sym-
metric chiral phosphine catalyst. Although γ-substituted allenes
have been employed in many phosphine-mediated γ-additions,
to date there was virtually no progress on the use of prochiral
pronucleophiles in phosphine-mediated γ-additions until the
group of Lu published in 2014 the addition of 3-substitued oxin-
doles [111]. More recently, Lu together with Lan also demon-
strated the efficiency of oxazol-4(5H)-ones and thiazol-4(5H)-
ones as pronucleophiles in the highly enantioselective phos-
phine-catalyzed asymmetric γ-addition to allenoates, which
after elaboration of the resulting adducts, affords tertiary
thioethers and alcohols [36] (Scheme 15).
Starting from readily available L-valine and L-threonine the
authors first synthesized different phosphine catalysts and then
screened in the γ-addition reaction of both, thiazol-4(5H)-ones
and oxazol-4(5H)-ones. They found that whilst catalyst C6 was
Beilstein J. Org. Chem. 2016, 12, 918–936.
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Scheme 15: Enantioselective γ-addition of oxazol-4(5H)-ones and thiazol-4(5H)-ones to allenoates promoted by C6/C7 [36].
Scheme 16: Enantioselective γ-addition of thiazol-4(5H)-ones and oxazol-4(5H)-ones to alkynoate 83 promoted by C6/C7 [36].
the best for the reaction with thiazol-4(5H)-ones, in the case of
oxazol-4(5H)-ones, however, best results were provided by
catalyst C7. The reaction conditions were further optimized by
varying both, the solvent and the ester moiety of the allenoate.
Examination of different allenoates revealed that the dibenzo-
suberyl ester provided the best results.
The scope of these catalysts was also proven in the reaction
with alkyne substrates. For instance, both thiazol-4(5H)-one 82
and oxazol-4(5H)-one 85 react with alkynoate 83 to provide
adducts 84 and 86, respectively, with equal efficiency than
allenoates (Scheme 16).
The authors propose the mechanism outlined in Scheme 17 on
the basis of some DFT calculations. Accordingly, the first step
is the γ-addition of the phosphine to the allenoate to produce
intermediate II. Then this basic intermediate is proposed to de-
protonate the starting thiazolone thus providing enolate V,
Beilstein J. Org. Chem. 2016, 12, 918–936.
931
Scheme 17: Proposed mechanism for the C6-catalyzed γ-addition of thiazol-4(5H)-one to allenoates. Adapted from [36], copyright 2015 The Royal
Society of Chemistry.
which subsequently adds to the γ-carbon of IV to afford inter-
mediate VI. After proton shift, intermediate VI becomes inter-
mediate VII and this eliminates the phosphine catalyst, which
enters a new catalytic cycle, while providing the final product
VIII. The authors propose a bifunctional behavior of the cata-
lyst, wherein a hydrogen bonding interaction between the
sulfonamide N–H and the thiazolone enolate controls its addi-
tion to the C–C double bond, which is the key step for asym-
metric induction.
2.2.2 α-Amination reactions. Thiazolones 2 have also been in-
vestigated in the α-amination reaction with tert-butyl azo-
dicarboxylate in the presence of the ureidopeptide like catalysts
C5 and C8 (Scheme 18) [85]. In these cases better enantioselec-
tivity was observed with catalyst C8, and thiazolones bearing
the quinoyl moiety provided once again better stereochemical
results than 2-naphthylthiazolones.
2.2.3 Iridium-catalyzed allylic substitution reactions. Allylic
substitution reactions catalyzed by cyclometalated iridium phos-
phoramidite complexes constitute a powerful tool for the con-
struction of C–C and C–heteroatom bonds [112] and have been
used in many synthetic applications [113]. However one of the
main limitations in the area is the lack of highly diastereo- and
Beilstein J. Org. Chem. 2016, 12, 918–936.
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Scheme 18: Catalytic enantioselective α-amination of thiazolones promoted by ureidopeptide like catalysts C5 and C8 [85].
enantioselective protocols. In this context, particularly difficult
has been to achieve high diastereoselectivity, and only a very
narrow range of nucleophiles have been reported to be efficient
in this regard (α,α-disubstituted aldehydes [114] and
β-ketoesters [115] among others). With the aim of expanding
the nucleophile scope of this transformation, in 2014 Hartwig et
al. reported a highly diastereoselective iridium-catalyzed allyla-
tion substitution reaction of oxazol-4(5H)-ones and thiazol-
4(5H)-ones to afford enantioenriched tertiary alcohols and
thioethers (Scheme 19) [42]. In this case the diastereoselectiv-
ity is controlled by cations, in contrast to most of the described
protocols wherein it is modulated by anions.
The authors found that whilst the best results for allylation of
oxazol-4-(5H)-ones were achieved from zinc enolates, thiazol-
4-(5H)-ones produced the best outcome when the magnesium
enolate was used. After optimization it was shown that the reac-
tion was efficient with different cinnamyl tert-butyl carbonates
(Scheme 19) to afford compounds 90–99in general with good
yields, diastereomeric ratios and enantioselectivities. Aliphatic
carbonates are also good substrates for this reaction but the cor-
responding adducts are obtained in lower diastereoselectivity.
This work demonstrates that the selectivity of the reaction is
dictated by the metallacyclic iridium complex and that the
nature of the enolate counterion is significant to this respect.
Conclusion
In this short review we have summarized the published exam-
ples of the utility of 2-thio-1H-imidazol-4(5H)-ones and
thiazol-4(5H)-ones as pronucleophiles in asymmetric catalytic
reactions. The results show that they are efficient substrates in
reactions which involve the creation of a tetrasubstituted stereo-
genic center. Further elaboration of adducts coming from these
reactions gives access to N-substitued α-amino acids in the case
of imidazolones and to tertiary thiols and thioethers in the case
of thiazolones. In the future, other Brønsted base or bifunc-
tional catalyst promoted reactions with these compounds can be
envisaged.
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Scheme 19: Iridium-catalized asymmetric allyllation of substituted oxazol-4(5H)-ones and thiazol-4(5H)-ones promoted by C9. PMP = p-methoxy-
phenyl [42].
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